Amylyx Pharmaceuticals, Inc. (AMLX)
NASDAQ: AMLX · Real-Time Price · USD
17.79
+0.35 (2.01%)
At close: Jun 26, 2026, 4:00 PM EDT
17.85
+0.06 (0.34%)
After-hours: Jun 26, 2026, 7:43 PM EDT
Amylyx Pharmaceuticals Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Amylyx Pharmaceuticals stock have an average target of 25.63, with a low estimate of 20 and a high estimate of 40. The average target predicts an increase of 44.07% from the current stock price of 17.79.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Amylyx Pharmaceuticals stock from 12 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 10 | 10 | 11 | 11 | 11 | 11 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 12 | 12 | 12 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Buy Maintains $30 → $40 | Buy | Maintains | $30 → $40 | +124.85% | Jun 25, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $34 | Buy | Reiterates | $34 | +91.12% | Jun 24, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Maintains $22 → $23 | Buy | Maintains | $22 → $23 | +29.29% | Jun 18, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $24 | Buy | Maintains | $24 | +34.91% | May 16, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Reiterates $21 | Buy | Reiterates | $21 | +18.04% | May 11, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
40.22M
EPS This Year
-1.38
from -1.53
EPS Next Year
-1.27
from -1.38
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | n/a | 125.7M | |
| Avg | n/a | 40.2M | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2027 | 2028 |
|---|---|---|
| High | - | 935.8% |
| Avg | - | 281.0% |
| Low | - | 6.9% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -1.05 | -0.54 | |
| Avg | -1.38 | -1.27 | |
| Low | -1.59 | -1.71 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.